The Clinical Study on Aluminum Levels in Patients Undergoing Hemodialysis.

Purpose : This study was performed to evaluate the aluminum level in hemodialysis patients and to find a correlation between aluminum level and bone specific alkaline phosphatase level. Methods : Eighty five randomly selected patients with end-stage renal disease, undergoing maintenance hemodialysis treatment over 1 year were studied. Serum aluminum and bone specific alkaline phosphatase concentration were measured. Low dose desferrioxamine test (5 mg/kg) was done. Results : The serum aluminum concentration before and after low dose desferrioxamine test were 4.21±2.13 μg/L and 8.89±4.48 μg/L (p